NCT02370602View on ClinicalTrials.gov

An [^11C]T-773 Positron Emission Tomography (PET) Study to Determine Phosphodiesterase10A Occupancy by TAK-063

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

March 31, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

TAK-063

TAK-063 tablets

DRUG

[^11C]T-773

\[\^11C\]T-773 IV solution

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY